SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
OncoMed Pharmaceuticals, Inc. Initiates Phase 1 Clinical Trial of Anti-Cancer Stem Cell Therapeutic OMP-52M51 (Anti-Notch1)